101 related articles for article (PubMed ID: 26028082)
21. Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients.
Roelofsen T; Mingels M; Hendriks JC; Samlal RA; Snijders MP; Aalders AL; Bulten J; van Ham MA; Massuger LF
Int J Biol Markers; 2012 Oct; 27(3):e263-71. PubMed ID: 22865295
[TBL] [Abstract][Full Text] [Related]
22. Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship.
Assem H; Rottmann D; Finkelstein A; Wang M; Ratner E; Santin AD; Buza N; Hui P
Hum Pathol; 2021 Dec; 118():1-8. PubMed ID: 34508766
[TBL] [Abstract][Full Text] [Related]
23. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
25. Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution.
Benito V; Lubrano A; Arencibia O; Alvarez EE; León L; Medina N; Falcón JM; Falcón O
Int J Gynecol Cancer; 2009 Nov; 19(8):1364-9. PubMed ID: 20009891
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.
Semaan A; Mert I; Munkarah AR; Bandyopadhyay S; Mahdi HS; Winer IS; Nucci MR; Hussein Y; Quershi F; Hayek K; Tabassum F; Alosh B; Schultz DS; Cote ML; Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
Int J Gynecol Pathol; 2013 Mar; 32(2):181-7. PubMed ID: 23370657
[TBL] [Abstract][Full Text] [Related]
27. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
28. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
29. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
[TBL] [Abstract][Full Text] [Related]
30. Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma.
Gupta D; Gunter MJ; Yang K; Lee S; Zuckerwise L; Chen LM; Goldberg GL; Huang GS
Int J Gynecol Cancer; 2011 Apr; 21(3):529-34. PubMed ID: 21436701
[TBL] [Abstract][Full Text] [Related]
31. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
[TBL] [Abstract][Full Text] [Related]
32. Preoperative CA-125, CA 19-9 and nuclear magnetic resonance in endometrial carcinoma: correlation with surgical stage.
Schneider J; Centeno M; Sáez F; Genollá J; Ruibal A
Tumour Biol; 1999; 20(1):25-9. PubMed ID: 9858872
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in endometrial clear cell carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Arch Gynecol Obstet; 2017 Jan; 295(1):189-195. PubMed ID: 27549092
[TBL] [Abstract][Full Text] [Related]
34. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
[TBL] [Abstract][Full Text] [Related]
35. Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas.
Miyamoto M; Takano M; Tsuda H; Soyama H; Aoyama T; Ishibashi H; Kato K; Iwahashi H; Matuura H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
Oncology; 2017; 93(1):29-35. PubMed ID: 28259868
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
37. CA 125 levels in the preoperative assessment of advanced-stage uterine cancer.
Jhang H; Chuang L; Visintainer P; Ramaswamy G
Am J Obstet Gynecol; 2003 May; 188(5):1195-7. PubMed ID: 12748476
[TBL] [Abstract][Full Text] [Related]
38. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
39. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
40. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
